Table 2: Clinical manifestation and CXR findings of study patients according to age.
|
Findings |
n = 159 (%) |
Age Group |
P value |
||||
|
60-64 year (n = 37) |
65-74 year (n = 58) |
75-84 year (n = 43) |
≥ 85 year (n = 21) |
||||
|
Signs and Symptoms |
|
|
|
|
|
|
|
|
Cough |
111 (69.81%) |
24 (64.86%) |
40 (68.97%) |
31 (72.09%) |
16 (76.19%) |
0.362 |
|
|
Loss of Appetite |
34 (21.38%) |
7 (18.92%) |
10 (17.24%) |
13 (30.23%) |
4 (19.05%) |
0.424 |
|
|
Body Weakness |
42 (26.42%) |
5 (13.51%) |
9 (15.52%) |
20 (46.51%) |
8 (38.1%) |
0.001 |
|
|
Difficulty of Breathing |
96 (60.38%) |
26 (70.27%) |
40 (68.97%) |
18 (41.86%) |
12 (57.14%) |
0.023 |
|
|
Fever |
53 (33.33%) |
12 (32.43%) |
17 (29.31%) |
17 (39.53%) |
7 (33.33%) |
0.758 |
|
|
Other Symptomsa |
76 (47.8%) |
18 (48.65%) |
29 (50%) |
23 (53.49%) |
6 (28.57%) |
0.285 |
|
|
Decrease in sensorium |
12 (7.55%) |
(0%) |
5 (8.62%) |
5 (11.63%) |
2 (9.52%) |
0.235 |
|
|
Hypotension |
13 (8.18%) |
4 (10.81%) |
3 (5.17%) |
6 (13.95%) |
(0%) |
0.185 |
|
|
Crackles |
124 (77.99%) |
31 (83.78%) |
37 (63.79%) |
39 (90.7%) |
17 (80.95%) |
0.009 |
|
|
Retractions |
16 (10.06%) |
4 (10.81%) |
7 (12.07%) |
3 (6.98%) |
2 (9.52%) |
0.864 |
|
|
Decrease Breath Sounds |
26 (16.35%) |
7 (18.92%) |
11 (18.97%) |
8 (18.6%) |
(0%) |
0.192 |
|
|
Others Signsb |
68 (42.77%) |
21 (56.76%) |
22 (37.93%) |
18 (41.86%) |
7 (33.33%) |
0.393 |
|
|
Vital Signs |
|
|
|
|
|
|
|
|
HR ≥ 30/min |
13 (8.18%) |
6 (16.22%) |
4 (6.9%) |
3 (6.98%) |
0 (0%) |
0.153 |
|
|
PR ≥ 125 |
7 (4.4%) |
2 (5.41%) |
3 (5.17%) |
2 (4.65%) |
0 (0%) |
0.767 |
|
|
Temp ≤ 36 or ≥ 40C |
3 (1.89%) |
0 (0%) |
1 (1.72%) |
2 (4.65%) |
0 (0%) |
0.408 |
|
|
SBP < 90 mmHg |
15 (9.43%) |
5 (13.51%) |
4 (6.9%) |
6 (13.95%) |
0 (0%) |
0.224 |
|
|
DBP ≤ 60 mmHg |
18 (11.32%) |
7 (18.92%) |
4 (6.9%) |
7 (16.28%) |
0 (0%) |
0.072 |
|
|
O2 Saturation < 90% |
41 (25.79%) |
13 (35.14%) |
15 (25.86%) |
9 (20.93%) |
4 (19.05%) |
0.437 |
|
|
CXR Findings |
|
|
|
|
|
|
|
|
Infiltrate |
121 (76.1%) |
30 (81.08%) |
40 (68.97%) |
35 (81.4%) |
16 (76.19%) |
0.425 |
|
|
Consolidation |
11 (6.92%) |
3 (8.11%) |
6 (10.34%) |
2 (4.65%) |
(0%) |
|
|
|
Pleural effusion |
17 (10.69%) |
1 (2.7%) |
9 (15.52%) |
5 (11.63%) |
2 (9.52%) |
|
|
|
Pneumonia Classification |
|
|
|
|
|
0.278 |
|
|
Moderate Risk |
127 (79.87%) |
32 (86.49%) |
44 (75.86%) |
32 (74.42%) |
19 (90.48%) |
|
|
|
High Risk |
32 (20.13%) |
5 (13.51%) |
14 (24.14%) |
11 (25.58%) |
2 (9.52%) |
|
|
|
Outcome at Discharge |
|
|
|
|
|
0.784 |
|
|
Survived |
122 (76.73%) |
29 (78.38%) |
42 (72.41%) |
33 (76.74%) |
18 (85.71%) |
|
|
|
Died |
37 (23.27%) |
8 (21.62%) |
16 (27.59%) |
10 (23.26%) |
3 (14.29%) |
|
|
p-value <0.5-significant; aOther symptoms: Chills, Rashes, chest pain, diaphoresis, easy fatigability, palpitation, bipedal edema, orthopnea, paroxysmal nocturnal dyspnea, abdominal pain, vomiting, melena, dysphagia, loose watery stool, hematemesis, headache, dizziness, loss of consciousness, slurring of speech; dysuria; hemoptysis; joint Pain; bOther Signs: anterior Neck Mass, neck vein distention, wheezes, irregular rhythm, bradycardia, tachycardia, abdominal distention.